Skip to main content

Table 4 Completion rates of measures amongst participants in the observation and pilot randomised controlled trial phase

From: Evaluation of a smartwatch-based intervention providing feedback of daily activity within a research-naive stroke ward: a pilot randomised controlled trial

Completion Observational phase (n = 20) Pilot RCT Phase (n = 30)
Feedback (n = 14) No feedback (n = 16)
Full (100%) Completion range Full (100%) Completion range Full (100%) Completion range
Performance-based outcomes (n = 5)*
 Baseline n = 3 n = 2 65–75% n = 2 n = 3 57–78% n = 0 n = 5 75–93%
 3 weeks n = 0 n = 5 55–70% n = 0 n = 5 50–85% n = 0 n = 5 62–75%
 12 weeks       
Self-report outcomes (n = 5)^
 Baseline n = 2 n = 3 90–95% n = 2 n = 3 85–92% n = 0 n = 5 87–93%
 3 weeks n = 0 n = 5 65–70% n = 0 n = 5 78–85% n = 0 n = 5 75%
 12 weeks (n = 3) n = 0 n = 3 35–45% n = 0 n = 3 42–50% n = 0 n = 3 50%
Smartwatch activity data
 Patient data recorded by watch and downloaded by ward staff n = 20 100% n = 14 100% n = 16 100%
 Smartwatch data recorded in log n = 4 20% n = 14 100% n = 16 100%
  1. Completion range refers to the percentage of recruited patients whom successfully completed assessment across measures
  2. *Grip strength left, grip strength right, 10-m walk test; MoCA, Montreal Cognitive Assessment (Mandarin version); BI, Barthel ADL Index
  3. ^FSS, Fatigue Severity Scale; VAF-S, Visual Analog Fatigue Scale; EQ-5D-5L, EuroQol Health Questionnaire, including the EQ VAS (Visual Analogue Scale); RMI, Rivermead Mobility Index; WHODAS, World Health Organization Disability Assessment Schedule (12-item)